Popular Pharmaceuticals Limited
Ashraful Islam is an experienced professional currently serving as a Sr. Officer at IFIC Bank Limited since January 2020 and also holds the position of Sales and Marketing Specialist at Popular Pharmaceuticals Limited since February 2018. Prior experience includes serving as an Officer at IFIC Bank Limited from June 2016 to April 2017 and pursuing a Graduate Student position at Eastern University from December 2014 to January 2016. Ashraful Islam earned a Master of Business Administration (MBA) from Eastern University, Bangladesh, from 2014 to 2016 and previously obtained a Bachelor of Science (B.Sc.) in Botany/Plant Biology from National University between 2007 and 2011.
Popular Pharmaceuticals Limited
The State of the Art manufacturing facilities of Popular Pharmaceuticals Ltd. (PPL), is located in an industrial area close to the International Airport of the capital city, Dhaka. The total land area of this site is 22,952 m2 with a covered area of 13,509 m2. The manufacturing site is built with strict compliance to WHO cGMP standards and also to meet US FDA and UK MHRA requirements. The project involved an investment of BDT 2,000 M (US$ 30 M approx.); the ever highest initial investment for a pharmaceutical plant in Bangladesh.Through captivating marketing strategies coupled with optimum productivity across all its activities with quality People, Plant and Product, PPL is committed to deliver top tier performance round the year. PPL is continuously investing in diversifying the ranges of products and services to complement the aura with all the major therapeutic areas. PPL aims to create enduring value for the society, and deliver a sustained financial performance that will match the best in the industry. Popular Pharmaceuticals Ltd. intends to focus its skills and resources on all major therapeutic areas that represent majority of the burden of disease profiles of Bangladesh. Popular Pharmaceuticals Ltd. is also committed to delivering new, medically important and commercially successful products to the market every year. Along with its commitment to competitiveness and high performance, PPL will continue to be led by its core values to achieve sustainable success. Efficient pharmaceutical business requires transparent, quality assured processes which are acceptable to regulatory authorities worldwide in addition to the use of complementary new technologies. PPL is committed to the best use of available technology and expertise of the time and thereby ensuring continuous improvements with regards to effectiveness and efficiency.